Loading…
Oaktree Acquisition Corp. III Life Sciences is projected to rise to $14.29 by 2027, a +34% move from its current price of $10.69. OACC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.67 | $10.70 | $10.73 | +0.10% |
| Jul 14 | $10.67 | $10.71 | $10.75 | +0.20% |
| Jul 15 | $10.67 | $10.72 | $10.77 | +0.29% |
| Jul 16 | $10.68 | $10.73 | $10.79 | +0.39% |
| Jul 17 | $10.68 | $10.74 | $10.81 | +0.49% |
| Jul 18 | $10.68 | $10.75 | $10.82 | +0.59% |
| Jul 19 | $10.69 | $10.76 | $10.84 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.69 | $10.76 | $10.84 | +0.69% |
| Week 2 | $10.73 | $10.84 | $10.94 | +1.38% |
| Week 3 | $10.78 | $10.91 | $11.04 | +2.08% |
| Week 4 | $10.84 | $10.99 | $11.14 | +2.78% |
| Week 5 | $10.89 | $11.06 | $11.23 | +3.48% |
| Week 6 | $10.95 | $11.14 | $11.33 | +4.19% |
| Week 7 | $11.01 | $11.21 | $11.42 | +4.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations and focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was founded in 1995 and is headquartered in Los Angeles, California.
The asset is categorized under Financial Services. This description reflects the company’s stated focus and structure as it seeks to pursue strategic combinations within the healthcare and life sciences space across North America and Europe.
Oaktree Acquisition Corp. III Life Sciences (OACC) is listed with a current price of $10.65 and a market capitalization of $261.81M. The stock is ranked 3392 by market capitalization in its category. The current price and position sit within a tight trading range as reflected by nearby moving averages and the 30-day range.
Forecasts project a multi-year upside, with the average price rising through 2029 and beyond. The 2030 average is $18.04, and the 2050 average reaches $84.99, with progressively higher maximums along the path. These figures imply substantial longer-term upside, though they are estimates and not guarantees.
A major floor 1.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.4% away) — a key level to hold.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 0.9% above — clearing it would confirm fresh momentum.
Key OACC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OACC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.69 | Buy | $10.69 | Sell |
| MA 10 | $10.70 | Sell | $10.69 | Sell |
| MA 20 | $10.68 | Buy | $10.68 | Buy |
| MA 50 | $10.66 | Buy | $10.67 | Buy |
| MA 100 | $10.66 | Buy | $10.65 | Buy |
| MA 200 | $10.63 | Buy | $10.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.60 | Neutral |
| Stoch RSI (14) | 32.43 | Neutral |
| CCI (20) | 38.09 | Neutral |
| Williams %R (14) | -55.56 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.28 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 44.44 | Neutral |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 49.93 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 10.68 | Buy |
| ADX (14) | 11.66 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture shows a bullish tilt overall. RSI(14) is 50, with the short- and longer-term moving averages hovering around the current price (SMA50 at $10.66 and SMA200 at $10.61).
Support is identified at $10.61 and resistance at $10.73, framing a narrow near-term corridor. The 30-day price range spans from $10.54 to $10.76, indicating limited volatility in the near term. Annualized volatility sits at 3%, underscoring a relatively stable short-term backdrop.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.56 | $10.69 | $14.75 | 0% | Neutral | |
| $11.70 | $14.29 | $18.24 | +34% | Bullish | |
| $12.76 | $15.87 | $20.81 | +48% | Bullish | |
| $14.47 | $18.28 | $24.48 | +71% | Bullish | |
| $14.26 | $18.26 | $24.89 | +71% | Bullish | |
| $14.89 | $19.30 | $26.72 | +81% | Bullish | |
| $17.71 | $23.20 | $32.58 | +117% | Bullish | |
| $19.95 | $26.42 | $37.59 | +147% | Bullish | |
| $22.35 | $29.89 | $43.03 | +180% | Bullish | |
| $23.73 | $32.04 | $46.64 | +200% | Bullish | |
| $35.12 | $49.45 | $75.43 | +363% | Bullish | |
| $57.31 | $86.56 | $141.52 | +710% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.56 | $10.69 | $12.84 | +0.00% |
| August 2026 | $9.75 | $11.41 | $13.64 | +6.74% |
| September 2026 | $9.94 | $11.69 | $14.08 | +2.43% |
| October 2026 | $9.81 | $11.58 | $14.05 | -0.89% |
| November 2026 | $9.89 | $11.72 | $14.30 | +1.21% |
| December 2026 | $10.12 | $12.03 | $14.75 | +2.64% |
Click any year to see its month-by-month OACC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OACC is projected to trade between $10.56 and $14.75, averaging $10.69 — a potential gain of 0% from today's $10.69. A consolidation phase looks the most probable path here.
Oaktree Acquisition Corp. III Life Sciences's 2027 outlook centres on $14.29, within a $11.70 to $18.24 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2028, OACC could reach as high as $20.81, with a base case around $15.87 and support toward $12.76 — roughly +48% from $10.69. Buyers look set to stay in control over this stretch.
Expect OACC to range from $14.47 to $24.48 through 2029. The $18.28 average target implies a +71% move from current prices. That is up +15% on the projected 2028 average. Momentum favours further upside here.
The OACC price prediction for 2030 points to an average of $18.26 (low $14.26, high $24.89) — a potential gain of +71% on today's $10.69. Buyers look set to stay in control over this stretch.
In 2031, OACC is projected to trade between $14.89 and $26.72, averaging $19.30 — a potential gain of +81% from today's $10.69. That is up +6% on the projected 2030 average. Momentum favours further upside here.
Oaktree Acquisition Corp. III Life Sciences's 2032 outlook centres on $23.20, within a $17.71 to $32.58 range. That is up +20% on the projected 2031 average. That marks a +117% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, OACC could reach as high as $37.59, with a base case around $26.42 and support toward $19.95 — roughly +147% from $10.69. Momentum favours further upside here.
Expect OACC to range from $22.35 to $43.03 through 2034. The $29.89 average target implies a +180% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The OACC price prediction for 2035 points to an average of $32.04 (low $23.73, high $46.64) — a potential gain of +200% on today's $10.69. Momentum favours further upside here.
In 2040, OACC is projected to trade between $35.12 and $75.43, averaging $49.45 — a potential gain of +363% from today's $10.69. That is up +54% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Oaktree Acquisition Corp. III Life Sciences's 2050 outlook centres on $86.56, within a $57.31 to $141.52 range. That is up +75% on the projected 2040 average. That marks a +710% change versus current levels. Momentum favours further upside here.
Investing $1,000 in OACC today (≈ 93.54537 OACC) could be worth
$8,096.83
+$7,096.83 (+710%) by 2050 · US Dollar
Based on the average projected OACC price of $86.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OACCwould be worth at today's price.
$1,000 invested in OACC on Jul 10, 2025 (≈ 96.107643 OACC) would be worth
$1,027.39
+$27.39 (+2.7%) today · 1.03× · US Dollar
Based on a OACC entry price of $10.4 vs. today's $10.69.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.74 | $995.34 | -0.5% |
| 1 month ago | $10.66 | $1,002.81 | +0.3% |
| 3 months ago | $10.65 | $1,003.76 | +0.4% |
| 6 months ago | $10.64 | $1,004.7 | +0.5% |
| 1 year ago | $10.4 | $1,027.39 | +2.7% |
| All time (1.6y) ago | $10 | $1,069 | +6.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OACC forecast.
Our base-case forecast reaches $21.00 around 2032.
Implied market cap at $21.00: $415.44M
The multi-year forecast points to a sustained bullish trajectory. The 2026 forecast is $10.65 on average with a neutral sentiment, followed by steady gains through 2030 (Avg $18.04, ROI 69.4%) and beyond. By 2031 the average rises to $19.61 (ROI 84.2%), and by 2032 the average is $23.34 (ROI 119.2%).
Notable milestones include 2033 with an average of $26.28 (ROI 146.7%), 2034 at $30.11 (ROI 182.7%), and 2035 at $32.07 (ROI 201.1%). The path continues to 2040 with an average of $50.50 (ROI 374.2%) and culminates in 2050 at $84.99 (ROI 698%). Max values along the years extend well beyond the averages, illustrating upside potential under the forecast.
The sentiment is bullish for 2027 onward through 2050, with higher upside implied by the later years.
Tap a question to reveal the answer.
Avg $18.04; ROI 69.4% (sentiment BULLISH).
Forecasts show bullish sentiment from 2027 onward, with 2030 Avg $18.04 and ROI 69.4%, 2040 Avg $50.50 and ROI 374.2%, 2050 Avg $84.99 and ROI 698%.
2032 max $32.80; 2032 min $17.80 and avg $23.34, indicating the potential for higher prices in the forecast horizon.
Current price is $10.65 and market cap is $261.81M.
Sentiment BULLISH; RSI(14) 50; SMA50 $10.66; SMA200 $10.61; support $10.61; resistance $10.73; 30-day range $10.54–$10.76; annualized volatility 3%.
Oaktree Acquisition Corp. III Life Sciences Community Discussion
0Share your Oaktree Acquisition Corp. III Life Sciences price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.